Study on the angiogenesis ability of Polymethyl methacrylate-mineralized collagen/Mg-Ca composite material in vitro and the bone formation effect in vivo
Source abstract
Abstract
Magnesium (Mg) and its alloys show high degrees of biocompatibility and biodegradability, used as biodegrad able materials in biomedical applications. In this study, Polymethyl methacrylate (PMMA) - mineralized collagen (nano-Hydroxyapatite/collagen; nHAC)/Mg-Ca composite materials were prepared, to study the angiogenesis ability of its composite materials on Human umbilical vein endothelial cells (HUVECs) and its osteogenesis effect in vivo. The results showed that the PMMA-nHAC reinforcement materials can promote the proliferation and adhesion in HUVECs of Mg matrix significantly, it can enhance the migration motility and VEGF expression of HUVECs. In vivo, Micro-CT examination showed that with coated samples presenting the highest bone formation. Histologically, the materials and their corrosion products caused no systematic or local cytotoxicological effects. Therefore, the Mg matrix composites prepared in the present study has good biocompatibility and PMMA-nHAC/Mg-Ca composite may be an ideal orthopedic material to improve the bone formation, and biodegradable magnesium based implants with bioactivity have potential applications in bone tissue.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Bone Tissue Engineering Materials · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Prosthodontics, The Second Affiliated Hospital of Jinzhou Medical University, Jinzhou, China
Beijing Key Laboratory of Information Service Engineering, Beijing Union University, Beijing, China
College of Robotics, Beijing Union University, Beijing, China
Funding
Natural Science Foundation of Liaoning Province · Department of Education of Liaoning Province · Beijing Union University
References (55)
Show source-provided references
1. 10.1002/adfm.20180540210.1002/adfm.201805402 ↗
2. 10.1186/s40902-020-00280-510.1186/s40902-020-00280-5 ↗
3. Liu Wei · J BIOMATER APPL · 2021 · 885328220987046
4. 10.1021/acsbiomaterials.7b0050610.1021/acsbiomaterials.7b00506 ↗
5. Toda Erina · Nanomaterials (Basel, Switzerland) · 2021 · 11
6. 10.1021/acsbiomaterials.9b0067210.1021/acsbiomaterials.9b00672 ↗
7. 10.1016/j.actbio.2018.02.01910.1016/j.actbio.2018.02.019 ↗
8. 10.1016/j.jmbbm.2015.09.02010.1016/j.jmbbm.2015.09.020 ↗
9. Majumdar J D · P NATL A SCI INDIA A · 2018 · 88 · 387
10. 10.1016/j.msea.2019.13827010.1016/j.msea.2019.138270 ↗
11. 10.1021/acsbiomaterials.0c0061310.1021/acsbiomaterials.0c00613 ↗
12. 10.1016/j.jmst.2017.07.01910.1016/j.jmst.2017.07.019 ↗
13. 10.3390/ma1010114910.3390/ma10101149 ↗
14. 10.1038/ncomms1388510.1038/ncomms13885 ↗
15. 10.3390/ma1306131510.3390/ma13061315 ↗
16. Liu L · NPG Asia Mater · 2019 · 81
17. 10.1002/jbm.a.3471810.1002/jbm.a.34718 ↗
18. 10.1016/j.jmbbm.2018.03.01610.1016/j.jmbbm.2018.03.016 ↗
19. 10.1016/j.msec.2017.03.26910.1016/j.msec.2017.03.269 ↗
20. 10.1016/j.actbio.2018.03.01410.1016/j.actbio.2018.03.014 ↗
21. 10.1002/mabi.20170033110.1002/mabi.201700331 ↗
22. Ruan Changshun · J R SOC INTERFACE · 2017 · 14 · 2016105710.1098/rsif.2016.1057 ↗
23. Jiang X · Int J Mol Med · 2018 · 41 · 2150
24. Liu C · Scanning · 2018 · 1
25. 10.1088/1748-605X/aadb4710.1088/1748-605X/aadb47 ↗
26. 10.1166/jbt.2018.170910.1166/jbt.2018.1709 ↗
27. Nie XJ · Regen Biomater · 2020 · 7 · 53
28. 10.1016/j.addr.2012.05.01510.1016/j.addr.2012.05.015 ↗
29. 10.1002/advs.20190020910.1002/advs.201900209 ↗
30. 10.1016/j.actbio.2016.11.06710.1016/j.actbio.2016.11.067 ↗
31. 10.1016/j.actbio.2019.09.01110.1016/j.actbio.2019.09.011 ↗
32. 10.1016/j.biomaterials.2015.01.06010.1016/j.biomaterials.2015.01.060 ↗
33. 10.1166/jbt.2020.222610.1166/jbt.2020.2226 ↗
34. 10.1016/j.enzmictec.2020.10967610.1016/j.enzmictec.2020.109676 ↗
35. Benlikaya R · 2009
36. PutriHayashi Tansza S. · CERAMICS INTERNATIONAL · 2020 · 20045
37. 10.1016/j.msec.2018.11.01810.1016/j.msec.2018.11.018 ↗
38. 10.1021/am508688510.1021/am5086885 ↗
39. 10.1016/j.bioactmat.2020.06.00910.1016/j.bioactmat.2020.06.009 ↗
40. 10.1016/j.actbio.2009.06.02810.1016/j.actbio.2009.06.028 ↗
41. 10.1016/j.biomaterials.2006.12.02710.1016/j.biomaterials.2006.12.027 ↗
42. 10.1016/j.biomaterials.2009.11.11110.1016/j.biomaterials.2009.11.111 ↗
43. Pan S · Exp Ther Med · 2020 · 14 · 4663
44. 10.1039/D0TB00074D10.1039/D0TB00074D ↗
45. 10.1002/advs.20200080010.1002/advs.202000800 ↗
46. 10.1016/j.biomaterials.2016.02.02310.1016/j.biomaterials.2016.02.023 ↗
47. 10.1016/j.bioactmat.2020.04.01910.1016/j.bioactmat.2020.04.019 ↗
48. 10.1016/j.compositesb.2020.10793710.1016/j.compositesb.2020.107937 ↗
49. 10.1002/adhm.20140039710.1002/adhm.201400397 ↗
50. 10.1038/s41598-019-53249-410.1038/s41598-019-53249-4 ↗
51. 10.1002/cnm.298910.1002/cnm.2989 ↗
52. 10.1088/1748-605X/aab8d610.1088/1748-605X/aab8d6 ↗
53. Chen Z, Yuen J, Crawford R, et al. The Effect of Osteoimmunomodulation on the Osteogenic Effects of Cobalt Incorporated β-tricalcium Phosphate. Biomaterials, 2015, pp. 126–138.10.1016/j.biomaterials.2015.04.044 ↗
54. 10.1016/j.msec.2019.02.10410.1016/j.msec.2019.02.104 ↗
55. 10.1039/C7RA05966C10.1039/C7RA05966C ↗